Immunovant, Inc. (IMVT)

NASDAQ

$26.02

-$0.40 (1.51%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$25.57$27.29

Open $26.73

52 Week Range

$12.72$28.08

Previous Close $26.42

Market Cap4.56B

Volume2.96M

Avg Volume1.74M

P/E (TTM)-9.72

EPS (TTM)$-2.68

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for Immunovant, Inc.

DEC112025

Immunovant Announces Pricing of $550 Million Common Stock Financing

Source: GlobeNewsWire•5 days ago

NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced the pricing of an underwritten offering of its co...

NOV102025

Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025

Source: GlobeNewsWire•35 days ago

Study in uncontrolled Graves' disease (GD) patients treated for 24 weeks showed first-ever potentially disease-modifying outcome with six-month off-treatment data IMVT-1402 development is progressing with potentially registrational studies in GD, mya...

OCT272025

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

Source: GlobeNewsWire•49 days ago

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m. ET on Monday, November 10, 202...